Table 1 Baseline characteristics of all patients with pathologic T3b after RP (Total N = 159).
N (%) or Mean ± SD | Negative SVI on MRI (N = 107) | Positive SVI on MRI (N = 52) | P |
|---|---|---|---|
Age, years | 67.0 ± 7.2 | 66.9 ± 7.7 | 0.951 |
BMI, kg/m2 | 24.6 ± 3.0 | 24.9 ± 3.3 | 0.556 |
Pre-biopsy PSA, ng/ml | 26.6 ± 29.7 | 62.5 ± 92.5 | 0.009 |
RP GS category | 0.041 | ||
3 + 4 | 7 (6.5%) | 1 (1.9%) | |
4 + 3 | 50 (46.7%) | 16 (30.8%) | |
≥4 + 4 | 50 (46.7%) | 35 (67.3%) | |
Pathologic ECE, yes | 88 (82.2%) | 48 (92.3%) | 0.099 |
Pathologic LNI, yes | 21 (21.4%) | 18 (34.6%) | 0.080 |
Pathologic PSM, yes | 43 (40.2%) | 40 (76.9%) | <0.001 |
Positive ECE on MRI | 41 (38.3%) | 42 (80.8%) | <0.001 |
Positive LNE on MRI | 16 (15.0%) | 16 (30.8%) | 0.020 |
BCR, yes | 25 (23.4%) | 20 (38.5%) | 0.047 |